Ranbaxy SWOT Analysis

Published in Pharma and Healthcare category by MBA Skool Team

Here is a detailed SWOT analysis of Ranbaxy covering strengths, weaknesses, opportunities and threats.

Ranbaxy Strengths

  1. Top 10 Global Generic Company with a spread over 125 countries
  2. over 13,000 well trained Employees, over 50 nationalities
  3. Strong presence in the International market with a major share and a strong presence in India as well
  4. It has operations in nearly 50 countries and has 7 manufacturing plants

Above are the strengths in the SWOT Analysis of Ranbaxy. The strengths of Ranbaxy looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Ranbaxy Weaknesses

  1. It is heavily dependent upon generics for its revenue generation
  2. Constantly regulated policies by the govt means operational efficiency is affected

These were the weaknesses in the Ranbaxy SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Read more about Ranbaxy

Ranbaxy Opportunities

  1. increasing health awareness
  2. Improvement in distribution network & brand building
  3. They can leverageSynriam, anti-malarial drug in brand building

Above we covered the opportunities in Ranbaxy SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Ranbaxy Threats

  1. Increasingly stringent FDA Regulations
  2. Exchange rate fluctuations
  3. Global economic slowdown

The threats in the SWOT Analysis of Ranbaxy are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Ranbaxy SWOT analysis.

Continue reading more about the brand/company.

About Ranbaxy

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Ranbaxy Overview
Parent Company

Ranbaxy

Category

Pharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

New boundaries, new Horizons; Trusted medicines healthier lives

USP

It is India’s largest pharmaceutical company

Ranbaxy STP
Segmentation

Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional

Target Market

Healthcare professionals, wholesalers, generic distributors, and hospitals

Positioning

A diversifies global healthcare company focused on patient’s needs


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Ranbaxy. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin